When examining anti-PD-1 responders and nonresponders in metastatic melanoma, scholars found a significantly higher correlation between CD3E and PD-1 between responders and nonresponders, which supports the tumor hypothesis related to CD3E expression in the microenvironment [28]. Here, CD3E is linked to metastatic melanoma.